UPDATE: H.C. Wainwright Starts Kazia Therapeutics (KZIA) at Buy, $17 PT
Tweet Send to a Friend
(Updated - January 5, 2021 6:40 AM EST)
H.C. Wainwright analyst Sean Lee initiates coverage on Kazia Therapeutics (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
H.C. Wainwright analyst Sean Lee initiates coverage on Kazia Therapeutics (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
